A M I No 16.23/2025 26 Denosumab Inj 120mg
Tender Title | A M I No 16.23/2025 26 Denosumab Inj 120mg | ||
Tender ID | NA | Tender Reference Number | 82252397 |
Tender Type | Open/advertised | ||
Tender Opening Date | 2025-01-07 06:11 AM | Tender Closing Date | 2025-02-10 05:30 AM |
Tender Value | Refer Document | Tender Location | New Delhi , Central Delhi , Delhi |
Tender Category | Goods | Product Category | Healthcare and Medicine Tenders |
ePublished Date | 2025-01-07 06:11 AM | Bid Opening Date | 2025-02-10 05:30 AM |
Document Download Start Date | 2025-01-07 06:11 AM | Document Download End Date | 2025-02-10 05:30 AM |
Bid Submission Start Date | 2025-01-07 06:11 AM | Bid Submission End Date | 2025-02-10 05:30 AM |
Clarification start Date | Clarification End Date | ||
Bid Validity Period (in Days) | NA |
Tender Fee | Refer document |
EMD (Earnest Money Deposit) | ₹ 1,30,890 |
EMD Fee Type | NA |
Payment Instruments/Mode | NA |
Work Description - For Complete Deion And Other Details, Please Refer To Tender
The Ministry of Railways, STORES/NORTHERN RLY (2nd Floor, Annexe-I Baroda House, K G Marg, New Delhi), invites tenders for the supply of A M I No - 16.23/2025-26 Denosumab Inj 120mg (Tender Reference Number: 82252397). This open tender, categorized as Goods under Railway related Products, requires a bid security (EMD) of ₹130,890. Tender documents are available for download from 07 January 2025, 11:41 AM to 10 February 2025, 11:00 AM. Bids must be submitted within the same timeframe, with the opening scheduled for 10 February 2025, 11:00 AM. For complete details, refer to the tender document. There is no tender fee.
Get Hassle free financing for your business
Office Inviting Bids | Stores/northern Rly |
Address | 2nd Floor, Annexe- I Baroda House, K G Marg New Delhi |
Contact Details | NA |
NA | |
Website | NA |
A M I No - 16.51/2025-26 Nimotuzumab Inj 200mg..read more
A M I No- 16.05/2025-26 Bevacizumab Inj 400mg..read more
A M I No - 16.67 / 2025-26 Ramucirumab Inj 500mg..read more
A M I No. 16.76 / 2025-26 Trastuzumab Inj. 440 Mg..read more
A M I No. 16.03 / 2025-26 Bevacizumab Inj. 100 Mg..read more
All the major brands in each raw material category